{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T06:34:09Z","timestamp":1773815649073,"version":"3.50.1"},"reference-count":16,"publisher":"Japanese Society of Internal Medicine","issue":"23","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2016]]},"DOI":"10.2169\/internalmedicine.55.7367","type":"journal-article","created":{"date-parts":[[2016,11,30]],"date-time":"2016-11-30T22:15:57Z","timestamp":1480544157000},"page":"3475-3478","source":"Crossref","is-referenced-by-count":18,"title":["A Renal Variant of Fabry Disease Diagnosed by the Presence of Urinary Mulberry Cells"],"prefix":"10.2169","volume":"55","author":[{"given":"Homare","family":"Shimohata","sequence":"first","affiliation":[{"name":"Department of Nephrology, Tokyo Medical University Ibaraki Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yujiro","family":"Ogawa","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Tokyo Medical University Ibaraki Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Maruyama","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Tokyo Medical University Ibaraki Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kouichi","family":"Hirayama","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Tokyo Medical University Ibaraki Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Tokyo Medical University Ibaraki Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Desnick RJ, Banikazemi M, Wasserstein M. Enzyme replacement therapy for Fabry disease, an inherited nephropathy. Clin Nephrol 57: 1-8, 2002.","DOI":"10.5414\/CNP57001"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Nakao S, Kodama C, Takenaka T, et al. Fabry disease: detection of undiagnosed hemodialysis patients and identification of a "renal variant" phenotype. Kidney Int 64: 801-807, 2003.","DOI":"10.1046\/j.1523-1755.2003.00160.x"},{"key":"3","unstructured":"3. Dincy PC, Karthik RK, Korula A, John D. Fabry's disease. J Assoc Physicians India 56: 242, 2008."},{"key":"4","unstructured":"4. Sawada K, Mizoguchi K, Hishida A, et al. Point mutation in the alpha-galactosidase A gene of atypical Fabry disease with only nephropathy. Clin Nephrol 45: 289-294, 1996."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Meroni M, Spisni C, Tazzari S, et al. Isolated glomerular proteinuria as the only clinical manifestation of Fabry's disease in an adult male. Nephrol Dial Transplant 12: 221-223, 1997.","DOI":"10.1093\/ndt\/12.1.221"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Saito O, Kusano E, Akimoto T, et al. Prevalance of Fabry disease in dialysis patients: Japan Fabry disease screening study (J-FAST). Clin Exp Nephrol 20: 284-293, 2016.","DOI":"10.1007\/s10157-015-1146-7"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Kikumoto Y, Sugiyama H, Morinaga H, et al. The frequency of Fabry disease with the E66Q variant in the \u03b1-galactosidase A gene in Japanese dialysis patients: a case report and a literature review. Clin Nephrol 78: 224-229, 2012.","DOI":"10.5414\/CN107097"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Doi K, Noiri E, Ishizu T, et al. High-throughput screening identified disease-causing mutants and functional variants of \u03b1-galactosidase A gene in Japanese male hemodialysis patients. J Hum Genet 57: 575-579, 2012.","DOI":"10.1038\/jhg.2012.68"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Ichinose M, Nakayama M, Ohashi T, Utsunomiya Y, Kobayashi M, Eto Y. Significance of screening for Fabry disease among male dialysis patients. Clin Exp Nephrol 9: 228-232, 2005.","DOI":"10.1007\/s10157-005-0369-4"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Rosenthal D, Lien YH, Lager D, et al. A novel \u03b1-galactosidase a mutant (M42L) identified in a renal variant of Fabry disease. Am J Kidney Dis 44: e85-e89, 2004.","DOI":"10.1016\/S0272-6386(04)01094-7"},{"key":"11","unstructured":"11. H Mukdsi J, Guti\u00e9rrez S, Barr\u00f3n B, et al. A renal variant of Fabry disease: a case with a novel Gal A hemizygote mutation. J Nephropathol 1: 194-197, 2012."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Lee NC, Niu DM, Lin CY, Hsiao KJ, Yang AH, Ng YY. Alpha-galactosidase activity should be examined in patients with proteinuria: what have we learned from a family affected with Fabry disease? Nephrol Dial Transplant 21: 549-550, 2006.","DOI":"10.1093\/ndt\/gfi191"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Nakamichi T, Miyazaki M, Nakayama K, et al. Fabry's disease discovered with chance urinary mulberry cells: a case report. CEN Case Rep 2: 49-52, 2013.","DOI":"10.1007\/s13730-012-0038-x"},{"key":"14","unstructured":"14. Kudo S, Kojima Y, Watanabe H, et al. A case of Fabry disease that was diagnosed by chance in urine sediment. Igaku Kensa 56: 875-878, 2007 (in Japanese)."},{"key":"15","unstructured":"15. Mitsuhashi F, Kobayashi H, Ishino M, et al. Mulberry cells in Fabry disease without renal insufficiency: a case report. J Nippon Med Sch 70: 583-584, 2003 (in Japanese)."},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Dobrovolny R, Dvorakova L, Ledvinova J, et al. Relationship between X-inactivation and clinical involvement in Fabry heterozygotes. Eleven novel mutations in the \u03b1-galactosidase A gene in the Czech and Slovak population. J Mol Med 83: 647-654, 2005.","DOI":"10.1007\/s00109-005-0656-2"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/55\/23\/55_55.7367\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T04:54:45Z","timestamp":1498366485000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/55\/23\/55_55.7367\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":16,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.55.7367","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}